Pseudomonas aeruginosa is a versatile opportunistic bacterial pathogen. We are interested in how P. aeruginosa evolves during both acute and chronic infections in humans.
Bacterial viruses known as bacteriophages or simply phages may be a weapon in the fight against multidrug resistant ‘superbugs’. Our team focuses on three aspects of phage therapy; finding new phages that may be suitable for therapy, applying phages in infection setting specific experimental models, and understanding and overcoming phage therapeutic failures. This research is funded by the Swiss Heart Foundation.